Cleared Traditional

K042172 - CLEO 90 INFUSION SET

K042172 is an FDA 510(k) clearance for CLEO 90 INFUSION SET, manufactured by Smiths Medical MD, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K042172 · Smiths Medical MD, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2004
Decision
57d
Days
Class 2
Risk

K042172 is an FDA 510(k) clearance for the CLEO 90 INFUSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Smiths Medical MD, Inc. (St. Paul, US). The FDA issued a Cleared decision on October 7, 2004 after a review of 57 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Smiths Medical MD, Inc. devices

FDA 510(k) Submission Details - K042172

510(k) Number K042172 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 2004
Decision Date October 07, 2004
Days to Decision 57 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 129d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 877
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K042172.
SOLUTION ADMINISTRATION WITH LUER ACCESS INJECTION SITE
K042936 · Baxter Healthcare Corp · Nov 2004
IV ADMINISTRATION SETS WITH ULTRABLOCK UV-RESISTANT TUBING
K041490 · B.Braun Medical, Inc. · Oct 2004
IV ADMINISTRATION SET B400 SP
K042693 · Codan US Corp. · Oct 2004
PERFUDROP AIR M-P WITH NEEDLE 20 G, MODEL 48451606
K041919 · Clinico · Oct 2004
EZ HUBER SAFETY INFUSION SET
K040533 · Pfm Medical, Inc. · Sep 2004
MODIFICATION TO: LIFTLOC SAFTEY INFUSION SET
K042234 · Specialty Health Products, Inc. · Sep 2004